A detailed history of Antonetti Capital Management LLC transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Antonetti Capital Management LLC holds 400 shares of PSTX stock, worth $3,752. This represents 0.0% of its overall portfolio holdings.

Number of Shares
400
Previous 100 300.0%
Holding current value
$3,752
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$1.62 - $2.79 $486 - $837
300 Added 300.0%
400 $0
Q4 2022

Feb 01, 2023

BUY
$3.33 - $6.38 $333 - $638
100 New
100 $0

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $805M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Antonetti Capital Management LLC Portfolio

Follow Antonetti Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Antonetti Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Antonetti Capital Management LLC with notifications on news.